Preoperative Glucagon-Like Peptide–1 Receptor Agonist Therapy and Prior Bariatric Surgery in Obese Patients Undergoing Total Knee Arthroplasty: Two Parallel National Propensity-Matched Analyses

Background Obesity is a risk factor for complications following total knee arthroplasty (TKA). With increasing use of glucagon-like peptide–1 receptor agonists (GLP-1RAs) and bariatric surgery, their comparative impact on TKA outcomes remains incompletely defined. Methods We conducted a retrospective cohort study using the TriNetX Research Network, identifying obese adults undergoing primary TKA between 2005 and 2023. Two independent propensity score–matched analyses were performed: (1) GLP-1RA users versus non–GLP-1RA/non-bariatric controls and (2) patients with prior bariatric surgery versus separate non–GLP-1 RA/non-bariatric controls. Medical complications within 90 days, surgical complications within two years, and healthcare utilization were evaluated. Results After matching, GLP-1RA use was associated with lower all-cause mortality and reduced periprosthetic joint infection (PJI) risk, and decreased 90-day readmissions, along with higher odds of revision surgery. Prior bariatric surgery was associated with reduced wound dehiscence and higher odds of revision surgery, without significant reductions in overall medical or surgical complication composites. Each exposure was compared with its own separately matched control cohort, and the two sets of estimates were not compared directly. Conclusions Among obese patients undergoing TKA, preoperative GLP-1RA therapy was associated with reduced infection and lower early healthcare utilization relative to matched controls, while prior bariatric surgery was associated with reduced wound dehiscence. Increased odds of revision surgery were observed in both exposures. These findings support a nuanced approach to preoperative risk assessment that extends beyond BMI reduction alone, and they should be interpreted as two parallel comparisons rather than as evidence favoring one strategy.

Authors

Institutions

Publication Details

Journal
Arthroplasty Today
Published
2026-11-19
DOI
https://doi.org/10.1016/j.artd.2026.102208
Primary Topic
Total Knee Arthroplasty Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Preoperative Glucagon-Like Peptide–1 Receptor Agonist Therapy and Prior Bariatric Surgery in Obese Patients Undergoing Total Knee Arthroplasty: Two Parallel National Propensity-Matched Analyses

Brett L. Hayden, Kevin A. Wu, Suraj Avinash Dhanjani, Calin Stefan Moucha et al.
6 links
Arthroplasty Today
Total Knee Arthroplasty Outcomes
article

Preoperative Glucagon-Like Peptide–1 Receptor Agonist Therapy and Prior Bariatric Surgery in Obese Patients Undergoing Total Knee Arthroplasty: Two Parallel National Propensity-Matched Analyses

Brett L. Hayden, Kevin A. Wu, Suraj Avinash Dhanjani, Calin Stefan Moucha, Christopher J. Warburton, Eric Mai, Junho Song, Ankit Choudhury, Michael Shatkin
article en

Abstract

Background Obesity is a risk factor for complications following total knee arthroplasty (TKA). With increasing use of glucagon-like peptide–1 receptor agonists (GLP-1RAs) and bariatric surgery, their comparative impact on TKA outcomes remains incompletely defined. Methods We conducted a retrospective cohort study using the TriNetX Research Network, identifying obese adults undergoing primary TKA between 2005 and 2023. Two independent propensity score–matched analyses were performed: (1) GLP-1RA users versus non–GLP-1RA/non-bariatric controls and (2) patients with prior bariatric surgery versus separate non–GLP-1 RA/non-bariatric controls. Medical complications within 90 days, surgical complications within two years, and healthcare utilization were evaluated. Results After matching, GLP-1RA use was associated with lower all-cause mortality and reduced periprosthetic joint infection (PJI) risk, and decreased 90-day readmissions, along with higher odds of revision surgery. Prior bariatric surgery was associated with reduced wound dehiscence and higher odds of revision surgery, without significant reductions in overall medical or surgical complication composites. Each exposure was compared with its own separately matched control cohort, and the two sets of estimates were not compared directly. Conclusions Among obese patients undergoing TKA, preoperative GLP-1RA therapy was associated with reduced infection and lower early healthcare utilization relative to matched controls, while prior bariatric surgery was associated with reduced wound dehiscence. Increased odds of revision surgery were observed in both exposures. These findings support a nuanced approach to preoperative risk assessment that extends beyond BMI reduction alone, and they should be interpreted as two parallel comparisons rather than as evidence favoring one strategy.

Arthroplasty TodayVol. 42
Medical College of Wisconsin (US), Icahn School of Medicine at Mount Sinai (US)
Good health and well-being
Total Knee Arthroplasty Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon